Gsk (GSK) Debt to Equity (2014 - 2025)
Gsk (GSK) recorded quarterly Debt to Equity of -$0.71 in Q4 2025, down 157.6% quarter-over-quarter from $1.24 in Q4 2024, and down 157.6% on a YoY basis from $1.24 in Q4 2024.
Gsk (GSK) Debt to Equity (2014 - 2025) Analysis & Trends
Gsk's Debt to Equity history runs 12 years deep, the most recent figure standing at -$0.71 for Q4 2025.
- In Q4 2025, Debt to Equity fell 157.6% year-over-year to -$0.71; the TTM figure through Dec 2025 stood at -$0.71 (down 157.6% YoY), while the FY2025 annual figure was -$0.71, down 157.6% from the prior year.
- Debt to Equity was -$0.71 for Q4 2025 at Gsk, down from $1.24 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $1.73 in Q4 2022 to a low of -$0.71 in Q4 2025.
- Historically, Debt to Equity has averaged $1.01 across 5 years, with a median of $1.35 in 2023.
- The sharpest annual moves came in 2022 and 2025: Debt to Equity increased 20.74% in 2022, then plunged 157.6% in 2025.
- A 5-year view of Debt to Equity shows it stood at $1.43 in 2021, then advanced by 20.74% to $1.73 in 2022, then declined by 21.98% to $1.35 in 2023, then retreated by 8.1% to $1.24 in 2024, then tumbled by 157.6% to -$0.71 in 2025.
- The last three Debt to Equity figures came in at -$0.71 (Q4 2025), $1.24 (Q4 2024), and $1.35 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 96,436,181.12 Bn | 96,436,176.16 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,017.30 Bn | 1,012.01 Bn | 16.22 Bn | 1.39 |
| 3 | Johnson & Johnson | 579.61 Bn | 557.55 Bn | 15.96 Bn | 0.68 |
| 4 | AbbVie | 402.30 Bn | 392.96 Bn | 10.78 Bn | -9.70 |
| 5 | Merck | 294.24 Bn | 288.59 Bn | 12.09 Bn | 1.07 |
| 6 | Amgen | 191.82 Bn | 179.78 Bn | 5.87 Bn | 6.24 |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 0.94 |
| 8 | Pfizer | 149.05 Bn | 136.28 Bn | -1.21 Bn | 0.72 |
| 9 | Bristol Myers Squibb | 116.33 Bn | 105.88 Bn | 8.07 Bn | 2.22 |
| 10 | Novartis Ag | 112.59 Bn | 111.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.71 |
| Dec 31, 2024 | 1.24 |
| Dec 31, 2023 | 1.35 |
| Dec 31, 2022 | 1.73 |
| Dec 31, 2021 | 1.43 |
| Dec 31, 2020 | 1.66 |
| Dec 31, 2019 | 2.13 |
| Dec 31, 2018 | 6.89 |
| Dec 31, 2017 | 4.59 |
| Dec 31, 2016 | 3.79 |
| Dec 31, 2015 | -1.73 |
| Dec 31, 2014 | -3.21 |